Medications & Supplements/Prescription Drugs

Teva Pharmaceuticals USA: Metoprolol Succinate Extended Release Tablets Recalled for Dissolution Failure

Agency Publication Date: October 25, 2018

Summary

Teva Pharmaceuticals has voluntarily recalled 53,451 bottles of Metoprolol Succinate Extended Release Tablets (50 mg). The recall was initiated because the tablets failed dissolution testing during routine stability checks, meaning the medication may not release properly into the body. This product is a prescription medication commonly used to treat high blood pressure and other heart conditions. Consumers who have these tablets should contact their healthcare provider to ensure their treatment remains effective.

Risk

The failure of the tablets to dissolve correctly can prevent the medication from being absorbed into the bloodstream at the intended rate, potentially reducing the effectiveness of the heart medication.

What You Should Do

Check your prescription bottle to see if you have Metoprolol Succinate Extended Release Tablets, USP 50 mg in 100-count bottles with NDC 62037-831-01.
Verify if your bottle matches lot number 1220211M with an expiration date of 02/2019.
Contact your healthcare provider or pharmacist immediately to discuss your treatment and obtain a replacement prescription if your medication is part of this recall.
Return any unused tablets from the affected lot to your pharmacy for a refund and further instructions.
Contact Teva Pharmaceuticals USA at 1090 Horsham Rd, North Wales, Pennsylvania, 19454-1505 for more information regarding this recall.
For additional questions, contact the FDA Consumer Complaint line at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.

Your Remedy Options

Full Refund

Healthcare consultation and pharmacy return

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Metoprolol Succinate Extended Release Tablets, USP 50 mg (100-count bottle)

Model:

NDC 62037-831-01

Recall #: D-0129-2019

Lot Numbers:

1220211M (Exp 02/2019)

Date Ranges: Expiration date 02/2019

Additional Information

Agency: Food and Drug Administration (FDA)

Event ID: 81326

Status: Resolved

Manufacturer: Teva Pharmaceuticals USA

Sold By: pharmacies

Manufactured In: United States

Units Affected: 53,451 bottles

Distributed To: Nationwide

Agency Last Updated: November 2, 2018

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.

Summary

What You Should Do

Check your prescription bottle to see if you have Metoprolol Succinate Extended Release Tablets, USP 50 mg in 100-count bottles with NDC 62037-831-01.

Verify if your bottle matches lot number 1220211M with an expiration date of 02/2019.

Contact your healthcare provider or pharmacist immediately to discuss your treatment and obtain a replacement prescription if your medication is part of this recall.

Return any unused tablets from the affected lot to your pharmacy for a refund and further instructions.

Contact Teva Pharmaceuticals USA at 1090 Horsham Rd, North Wales, Pennsylvania, 19454-1505 for more information regarding this recall.

For additional questions, contact the FDA Consumer Complaint line at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls.